O. Naismith

发表

Consensus Guidelines and Contouring Atlas for Pelvic Node Delineation in Prostate and Pelvic Node Intensity Modulated Radiation Therapy.

John Staffurth, Emma Hall, Helen McNair, 2015, International journal of radiation oncology, biology, physics.

Additional Treatments to the Local tumour for metastatic prostate cancer-Assessment of Novel Treatment Algorithms (IP2-ATLANTA): protocol for a multicentre, phase II randomised controlled trial

V. Khoo, H. Ahmed, J. McGrath, 2021, BMJ Open.

Provision of Organ at Risk Contouring Guidance in UK Radiotherapy Clinical Trials.

D. Eaton, E. Miles, R. Simões, 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

Comparison of hypofractionated high-dose intensity-modulated radiotherapy schedules for prostate cancer: Results from the phase III randomized CHHiP trial (CRUK/06/016).

D. Dearnaley, V. Khoo, J. Logue, 2016 .

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial.

J. Staffurth, V. Hinder, E. Hall, 2022, The Lancet. Oncology.

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

Annie Gao, Clare Griffin, John Staffurth, 2016, The Lancet. Oncology.

Estimates of Alpha/Beta (α/β) Ratios for Individual Late Rectal Toxicity Endpoints: An Analysis of the CHHiP Trial

D. Dearnaley, E. Hall, S. Gulliford, 2021, International journal of radiation oncology, biology, physics.

Derivation of dose/volume constraints for the anorectum from clinician and patient-reported outcomes in the CHHiP trial of radiotherapy fractionation.

D. Dearnaley, E. Hall, S. Gulliford, 2020, International journal of radiation oncology, biology, physics.

Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial

D. Dearnaley, V. Khoo, C. Parker, 2019, Clinical and translational radiation oncology.

Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial

G. Rodrigues, J. Staffurth, T. Tsakiridis, 2019, The Lancet. Oncology.

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial.

Annie Gao, John Staffurth, Peter Kirkbride, 2012, The Lancet. Oncology.

Results of a Large Scale Neutron Spectrometry and Dosimetry Comparison Exercise at the Cadarache Moderator Assembly

H. Klein, F. Posny, G. Taylor, 1997 .

A Database of Neutron Spectra, Instrument Response Functions, and Dosimetric Conversion Factors for Radiation Protection Applications

O. Naismith, B. Siebert, 1997 .

Developments in neutron spectrometry for radiation protection

David J. Thomas, Olivia Naismith, O. Naismith, 1995, Applications of Nuclear Techniques: Neutrons and their Applications.

Manual for SPKTBIB: a pc-based catalogue of neutron spectra.

O. Naismith, B. Siebert, 1996 .

Response of Neutron Dosemeters in Radiation Protection Environments: An Investigation of Techniques to Improve Estimates of Dose Equivalent

O. Naismith, B. Siebert, D. Thomas, 1997 .

Radiation Quantities: Significance of the Angular and Energy Distribution of the Radiation Field

O. Naismith, M. Marshall, C. Perks, 1994 .

PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018)

J. Staffurth, A. Henry, C. Cruickshank, 2020, Clinical and translational radiation oncology.

A comparison of treatment planning techniques used in two randomised UK external beam radiotherapy trials for localised prostate cancer.

D. Dearnaley, V. Khoo, A. Norman, 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

PEARLS – A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA‐avid pelvic and/or para-aortic lymph nodes at presentation

J. Staffurth, E. Miles, C. Cruickshank, 2022, Clinical and translational radiation oncology.

Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)

D. Dearnaley, V. Khoo, J. Staffurth, 2019, International journal of radiation oncology, biology, physics.

Evaluation and development of an image-guided radiotherapy protocol for prostate and nodes

A. Carver, O. Naismith, A. Baker, 2017, Journal of Radiotherapy in Practice.

A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer

D. Dearnaley, V. Khoo, C. Parker, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Forward- and Inverse-Planned Intensity-Modulated Radiotherapy in the CHHiP Trial: A Comparison of Dosimetry and Normal Tissue Toxicity

D. Dearnaley, V. Khoo, S. Hassan, 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

PACE-A: An international phase 3 randomised controlled trial (RCT) comparing stereotactic body radiotherapy (SBRT) to surgery for localised prostate cancer (LPCa)—Primary endpoint analysis.

A. Thompson, C. Griffin, E. Hall, 2023, Journal of Clinical Oncology.

Radiotherapy Quality Assurance for the CHHiP Trial: Conventional Versus Hypofractionated High-Dose Intensity-Modulated Radiotherapy in Prostate Cancer.

D. Dearnaley, V. Khoo, C. Clark, 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

PACE: Analysis of acute toxicity in PACE-B, an international phase III randomized controlled trial comparing stereotactic body radiotherapy (SBRT) to conventionally fractionated or moderately hypofractionated external beam radiotherapy (CFMHRT) for localized prostate cancer (LPCa).

J. Staffurth, V. Hinder, C. Griffin, 2019, Journal of Clinical Oncology.

8LBA 5 year outcomes of a phase III randomised trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): report from the CHHiP Trial Investigators Group

D. Dearnaley, V. Khoo, J. Logue, 2015 .

Gastrointestinal Toxicity Prediction Not Influenced By Rectal Contour or Dose-Volume Histogram Definition: Toxicity Prediction with Different Rectal Definitions.

D. Dearnaley, E. Hall, S. Gulliford, 2023, International journal of radiation oncology, biology, physics.

OC-0289 Comparison of side effects at 2 years in the randomised PACE-B trial (SBRT vs standard radiotherapy)

J. Staffurth, C. Griffin, W. Chu, 2021, Radiotherapy and Oncology.

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

D. Dearnaley, V. Khoo, C. Parker, 2016, The Lancet. Oncology.

Title : A randomised assessment of image guided radiotherapy within a phase 3 trial of Conventional or Hypofractionated High Dose Intensity Modulated Radiotherapy for Prostate Cancer ( CHHiP )

Parker, D. Dearnaley, V. Khoo, 2018 .

Title Radiotherapy Quality Assurance for the CHHiP Trial : Conventional versus Hypofractionated High-dose Intensity-modulated Radiotherapy in Prostate Cancer

D. Dearnaley, V. Khoo, C. Clark, 2019 .

Need for consensus when prescribing stereotactic body radiation therapy for prostate cancer.

D. Eaton, A. Henry, O. Naismith, 2015, International journal of radiation oncology, biology, physics.